Publications 

1. Prakash S, Srivastava R, Coulon PG, Dhanushkodi NR, Chentoufi AA, Tifrea DF, Edwards RA, Figueroa CJ, Schubl SD, Hsieh L, Buchmeier MJ, Bouziane M, Nesburn AB, Kuppermann BD, BenMohamed L. Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines. J Immunol. 2021 Apr 28:ji2001438. doi: 10.4049/jimmunol.2001438. Epub ahead of print. PMID: 33911008. (Impact Factor: 5.422, Citations: 6)

2. Pierre-Gregoire Coulon, Swayam Prakash, Nisha R. Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, J. Figueroa Cesar, Sebastian D. Schubl, Lanny Hsieh, Anthony B. Nesburn, Baruch D. Kuppermann, Elmostafa Bahraoui, Hawa Vahed, Daniel Gil, Trevor M. Jones, Jeffrey B. Ulmer, Lbachir BenMohamed. High Frequencies of PD-1+TIM3+TIGIT+CTLA4+ Functionally Exhausted SARS-CoV-2-Specific CD4+ and CD8+ T Cells Associated with Severe Disease in Critically ill COVID-19 Patients. bioRxiv 2022.01.30.478343; doi: https://doi.org/10.1101/2022.01.30.478343

3. Dhanushkodi NR, Prakash S, Srivastava R, et al. Antiviral CD19+CD27+ Memory B Cells Are Associated with Protection from Recurrent Asymptomatic Ocular Herpes Infection [published online ahead of print, 2022 Jan 5]. J Virol. 2022;jvi0205721. doi:10.1128/jvi.02057-21 (Impact Factor: 4.5, Citations: none)

4. Chentoufi AA, Dhanushkodi NR, Srivastava R, Prakash S, Coulon PA, Zayou L, Vahed H, Chentoufi HA, Hormi-Carver KK, BenMohamed L. Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back. Front Immunol. 2022 Apr 25;13:849515. doi: 10.3389/fimmu.2022.849515. PMID: 35547736; PMCID: PMC9082490.

5. Prasad N, Yadav B, Prakash S, Yadav D, Singh A, Gautam S, Bhadauria D, Kaul A, Patel MR, Behera MR, Kushwaha RS, Yachha M. Association of Human Leucocyte Antigen Polymorphism with Coronavirus Disease 19 in Renal Transplant Recipients. Vaccines (Basel). 2022 Oct 30;10(11):1840. doi: 10.3390/vaccines10111840. PMID: 36366349.

6. Prakash S, Roy S, Srivastava R, Coulon PG, Dhanushkodi NR, Vahed H, Jankeel A, Geertsema R, Amezquita C, Nguyen L, Messaoudi I, Burkhardt AM, BenMohamed L. Unique molecular signatures of antiviral memory CD8+ T cells associated with asymptomatic recurrent ocular herpes. Sci Rep. 2020 Aug 14;10(1):13843. doi: 10.1038/s41598-020-70673-z. PMCID: PMC7427992. (Impact Factor: 5.133, Citations: 1)

7. Dhanushkodi NR, Srivastava R, Coulon PG, Prakash S, Roy S, Bagnol D, Eveleth D, BenMohamed L. Healing of Ocular Herpetic Disease Following Treatment With an Engineered FGF-1 Is Associated With Increased Corneal Anti-Inflammatory M2 Macrophages. Front Immunol. 2021;12:1296. doi: 10.3389/fimmu.2021.673763 (Impact Factor: 7.561, Citations: none)

8. Dhanushkodi N, Prakash S, Srivastava R, Coulon PGA, Vahed H, Zayou L, Quadiri A, Schaefer H, BenMohamed L. A Prime/Pull RR2/CXCL11 Therapeutic Vaccine that Bolsters the Number and Function of Dorsal Root Ganglia Tissue-Resident HSV-Specific CD8+ TRM Cells Protects Latently Infected Guinea Pigs from Recurrent Genital Herpes. bioRxiv 2022.07.22.501208; doi: https://doi.org/10.1101/2022.07.22.501208

9. Coulon PG, Roy S*, Prakash S*, Srivastava R, Dhanushkodi N, Salazar S, Amezquita C, Nguyen L, Vahed H, Nguyen AM, Warsi WR, Ye C, Carlos-Cruz EA, Mai UT, BenMohamed L. Upregulation of Multiple CD8+ T Cell Exhaustion Pathways Is Associated with Recurrent Ocular Herpes Simplex Virus Type 1 Infection. J Immunol. 2020 Jul 15;205(2):454-468. doi: 10.4049/jimmunol.2000131. Epub 2020 Jun 15. PMID: 32540992; PMCID: PMC7343593. (Impact Factor: 5.422, Citations: 4)

10. Vipin VP, Zaidi G, Watson K, G Colman P, Prakash S, Agrawal S, Bhatia V, Dabadghao P, Bhatia E. High prevalence of idiopathic (islet antibody-negative) type 1 diabetes among Indian children and adolescents. Pediatr Diabetes. 2021 Feb;22(1):47-51. doi: 10.1111/pedi.13066. Epub 2020 Jul 29. PMID: 32558116. (Impact Factor: 4.267, Citations: 3)

11. Coulon PG, Dhanushkodi N, Prakash S, Srivastava R, Roy S, Alomari NI, Nguyen AM, Warsi WR, Ye C, Carlos-Cruz EA, Mai UT, Cruel AC, Ekmekciyan KM, Pearlman E, BenMohamed L. NLRP3, NLRP12, and IFI16 Inflammasomes Induction and Caspase-1 Activation Triggered by Virulent HSV-1 Strains Are Associated With Severe Corneal Inflammatory Herpetic Disease. Front Immunol. 2019 Jul 16;10:1631. doi:10.3389/fimmu.2019.01631. eCollection 2019. PubMed PMID: 31367214. (Impact Factor: 7.561, Citations: 19)

12. Prakash S, Agrawal S. Significance of killer cell immunoglobulin-like receptors in autoimmune diseases. Clin Immunol. 2020 May 3:108449. doi: 10.1016/j.clim.2020.108449. PubMed PMID: 32376502 (Impact Factor: 3.969, Citations: 8)

13. Srivastava R, Coulon PG, Prakash S, Dhanushkodi N, Roy S, Nguyen A, Alomari N, Mai U, Amezquita C, Ye C, Maillere B, BenMohamed L. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multi-Functional Effector Memory CD4+ TEM Cells in Asymptomatic Individuals and Protect from Ocular Herpes Infection and Disease in “Humanized” HLA-DR Transgenic Mice. J Virol. 2020 Mar 17;94(7):e01991-19. doi: 10.1128/JVI.01991-19. PubMed PMID: 31915285 (Impact Factor: 4.501, Citations: 3)

14. Dhanushkodi N, Srivastava R, Prakash S, Roy S, Coulon PG, Vahed H, BenMohamed L. High Frequency of IFN-g-Producing PLZFl+ RORγ+ iNKT1 Cells Infiltrating HSV-1 Infected Cornea is Associated with Protection from Ocular Herpes Infection and Disease. J Virol. 2020 Apr 16;94(9):e00140-20. doi: 10.1128/JVI.00140-20. PubMed PMID: 32102882 (Impact Factor: 4.501, Citations: 1)

15. Vahed H, Agrawal A, Srivastava R, Prakash S, Coulon PA, Roy S, BenMohamed L. Unique Type I Interferon, Expansion/Survival Cytokines and JAK/STAT Gene Signatures of Multi-Functional HSV- Specific Effector Memory CD8(+) T(EM) Cells Are Associated with Asymptomatic Ocular Herpes in Humans. J Virol. 2018 Nov 28. pii: JVI.01882-18. doi: 10.1128/JVI.01882-18. PubMed PMID: 30487281. (Impact Factor: 4.501, Citations: 13)

16. Roy S, Coulon PG, Prakash S, Srivastava R, Geertsema R, Dhanushkodi N, Lam C, Nguyen V, Gorospe E, Nguyen AM, Salazar S, Alomari NI, Warsi WR, BenMohamed L. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8(+) T(RM) Cells and Reduces Ocular Herpes Simplex Infection and Disease in HLA Transgenic Rabbits. J Virol. 2019 Aug 28;93(18). pii: e00827-19. PubMed PMID: 31217250. (Impact Factor: 4.501, Citations: 18)

17. Prakash S, Ranjan P, Ghoshal U, Agrawal S. KIR-like activating natural killer cell receptors and their association with complicated malaria in north India. Acta Trop. 2018 Feb; 178:55-60. doi: 10.1016/j.actatropica.2017.10.026. PubMed PMID: 29111138. (Impact Factor: 3.112, Citations: 3)

18. Prakash S, Sarangi AN, Alam S, Sonawane A, Sharma RK, Agrawal S. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival. Gene. 2017 Sep 20. pii: S0378-1119(17)30754-0. doi: 10.1016/j.gene.2017.09.033. PubMed PMID: 28942035. (Impact Factor: 2.319, Citations: 3)

19. Prakash S, Patel MR, Agrawal S, Jindal RM, Prasad N. Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes. Kidney Int Rep. 2017 Oct 24;3(2):321-327. doi:10.1016/j.ekir.2017.10.008. eCollection 2018 Mar. PubMed PMID: 29725635 (Impact Factor: 4.164, Citations: 4)

20. Prakash S, Sarangi AN, Tripathi G, Sharma RK, Agrawal S. Prediction of susceptible biomarkers for end stage renal disease among North Indians. Nephrology (Carlton). 2016 Jul;21(7):592-600. doi: 10.1111/nep.12635. PubMed PMID: 26421528. (Impact Factor: 1.913, Citations: 6)

21. Prakash S, Agrawal S. Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice. Curr Drug Metab. 2016;17(9):862-876. Review. PubMed PMID: 27494310. (Impact Factor: 2.96, Citations: 8)

22. Prakash S, Agrawal S, Kumar S, Prasad N. Impact of vascular endothelial growth factor single nucleotide polymorphism association on acute renal allograft rejection. Nephron. 2015;129(2):91-6. doi: 10.1159/000368700. Epub 2015 Jan 31. PubMed PMID: 25659610. (Impact Factor: 2.847, Citations: 9)

23. Prakash S, Alam S, Bharadwaj U, Aggarwal A, Mishra RN, Agrawal S. Associations of killer cell immunoglobulin like receptors with rheumatoid arthritis among North Indian population. Hum Immunol. 2014 Aug;75(8):802-7. doi:10.1016/j.humimm.2014.05.014. Epub 2014 Jun 6. PubMed PMID: 24912006. (Impact Factor: 2.85, Citations: 21)

24. Prakash S, Alam S, Faridi RM, Sonawane A, Agrawal S. Killer immunoglobulin like receptor gene content diversity among Northern Indian population. Ann Hum Biol. 2014 Nov-Dec;41(6):540-7. doi: 10.3109/03014460.2014.899624. Epub 2014 Apr 1. PubMed PMID: 24689793. (Impact Factor: 1.24, Citations: 2)

25. Prakash S, Alam S, Sharma RK, Sonawane A, Imran M, Agrawal S. Distribution of Killer cell immunoglobulin like receptor genes in end stage renal disease among North Indian population. Hum Immunol. 2013 Oct;74(10):1339-45. doi:10.1016/j.humimm.2013.06.015. Epub 2013 Jun 15. PubMed PMID: 23777934. (Impact Factor: 2.85, Citations: 14)

26. Prakash S, Prasad N, Sharma RK, Faridi RM, Agrawal S. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease. Cytokine. 2012 May;58(2):261-6. doi: 10.1016/j.cyto.2012.01.020. Epub 2012 Feb 26. PubMed PMID: 22370607. (Impact Factor: 3.488, Citations: 33)

27. Jaswani P*, Prakash S*, Prasad N, Agrawal S, Sharma RK. Predicting miRNA association with corresponding target genes and single nucleotide polymorphisms in altered renal pathophysiology. Microrna. 2017 Oct 16. doi: 10.2174/2211536606666171016151846. PubMed PMID: 29034845. (Impact Factor: 3.386, Citations: 5)

28. Alam S*, Rangaswamy D*, Prakash S*, Sharma RK, Khan MI, Sonawane A, Agrawal S. Impact of killer immunoglobulin-like receptor-human leukocyte antigens ligand incompatibility among renal transplantation. Indian J Nephrol. 2015 Jan-Feb;25(1):27-33. doi: 10.4103/0971-4065.134655. PubMed PMID: 25684869; PubMed Central PMCID: PMC4323909. (Impact Factor: 0.63, Citations: 4)

29. Agrawal D*, Prakash S*, Misra MK*, Phadke SR, Agrawal S. Implication of HLA-G 5' upstream regulatory region polymorphisms in idiopathic recurrent spontaneous abortions. Reprod Biomed Online. 2015 Jan;30(1):82-91. doi:10.1016/j.rbmo.2014.09.015. Epub 2014 Oct 16. PubMed PMID: 25457193. (Impact Factor: 3.828, Citations: 25)

30. Pandey M*, Sarangi AN*, Prakash S*, Agrawal S. MASS KIR Analyzer: An In Silico Approach for Analyzing the Killer Immunoglobulin Receptor Gene Content and its Diversity. Current Bioinformatics, 2015; 10(3):292-298. doi: 10.2174/1574893609999140918200855 (Impact Factor: 2.068, Citations: 3)

31. Prakash S, Misra MK, Agrawal S. Non-classical HLA-G allelic diversity among North Indians and their comparison with other populations. Anthropol Open J. 2016; 1(2): 27-35. (Impact Factor: -, Citations: 2)

32. Mastana S, Prakash S, Akam EC, Kirby M, Lindley MR, Sinha N, Agrawal S. Genetic association of pro inflammatory cytokine gene polymorphisms with coronary artery disease (CAD) in a North Indian population. Gene. 2017 Jul 21. pii: S0378-1119(17)30574-7. doi: 10.1016/j.gene.2017.07.050. PubMed PMID: 28739396. (Impact Factor: 2.319, Citations: 17)

33. Jaswani P, Prakash S, Dhar A, Sharma RK, Prasad N, Agrawal S. MicroRNAs Involvement in Renal Pathophysiology: A Bird's Eye View. Indian J Nephrol. 2017 Sep-Oct;27(5):337-341. doi: 10.4103/ijn.IJN_264_16. Review. PubMed PMID: 28904427 (Impact Factor: 0.63, Citations: 16)

34. Misra MK, Prakash S, Moulik NR, Kumar A, Agrawal S. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians. Hum Immunol. 2016 Jan;77(1):41-6. doi: 10.1016/j.humimm.2015.10.009. PubMed PMID: 26472014. (Impact Factor: 2.85, Citations: 20)

35. Misra MK, Prakash S, Kapoor R, Pandey SK, Sharma RK, Agrawal S. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease. Tissue Antigens. 2013 Nov;82(5):317-26. doi: 10.1111/tan.12210. Epub 2015 Oct 21. PubMed PMID: 24131018. (Impact Factor: 4.513, Citations: 40)

36. Verma PK, Prakash S, Parveen F, Faridi RM, Agrawal S. Genetic association of adipokine and UCP2 polymorphism with recurrent miscarriage among non-obese women. Reprod Biomed Online. 2012 Nov;25(5):527-35. doi: 10.1016/j.rbmo.2012.07.006. Epub 2012 Jul 20. PubMed PMID: 22995745. (Impact Factor: 3.828, Citations: 16)

37. Gupta R, Prakash S, Parveen F, Agrawal S. Association of CTLA-4 and TNF-α polymorphism with recurrent miscarriage among North Indian women. Cytokine. 2012 Nov;60(2):456-62. doi: 10.1016/j.cyto.2012.05.018. Epub 2012 Jun 22. PubMed PMID: 22727980. (Impact Factor: 3.488, Citations: 45)

38. Chauhan TS, Prakash S, Sharma RK, Agrawal S. Correlation of activating Killer immunoglobulin like receptor genes with the rate of cytomegalovirus infection in renal transplantation cases. J Genet Genome Res 2014, 1:1 (Impact Factor: -, Citations: -)

39. Agrawal S, Prakash S, Sharma RK. Genetics of familial focal segmental glomerulosclerosis. Clinical Queries: Nephrology. 2014; 3(2-4): 57-72 (Impact Factor: -, Citations: 1)

40. Gupta D, Gupta V, Singh V, Prakash S, Agrawal S, Chawla S, Phadke SR. Vascular endothelial growth factor gene polymorphisms and association with age related macular degeneration in Indian patients. Meta Gene. 2016 Jul 22;9:249-53. doi:10.1016/j.mgene.2016.07.011. PubMed PMID: 27617226. (Impact Factor: 0.54, Citations: 12)

41. Agrawal S, Parveen F, Faridi RM, Prakash S. Interleukin-1 gene cluster variants and recurrent pregnancy loss among North Indian women: retrospective study and meta-analysis. Reprod Biomed Online. 2012 Mar;24(3):342-51. doi:10.1016/j.rbmo.2011.11.021. Epub 2011 Dec 10. PubMed PMID: 22285242. (Impact Factor: 3.828, Citations: 33)

42. Mishra K, Behari A, Kapoor VK, Khan MS, Prakash S, Agrawal S. Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer. Asian Pac J Cancer Prev. 2015;16(14):5647-54. PubMed PMID: 26320430. (Impact Factor: 3.38, Citations: 6)

43. Mishra K, Behari A, Kapoor VK, Khan MS, Prakash S, Agrawal S. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer. J Gastroenterol Hepatol. 2013 Oct;28(10):1678-85. doi: 10.1111/jgh.12343. PubMed PMID: 23962084. (Impact Factor: 4.029, Citations: 11)

44. Misra MK, Pandey SK, Kapoor R, Sharma RK, Kapoor R, Prakash S, Agrawal S. HLA-G gene expression influenced at allelic level in association with end stage renal disease and acute allograft rejection. Hum Immunol. 2014 Aug;75(8):833-9. doi: 10.1016/j.humimm.2014.06.005. Epub 2014 Jun 11. PubMed PMID: 24929145 (Impact Factor: 2.85, Citations: 28)

Also, published the following epidemiology-based papers in collaboration with the Global Burden of Disease study

45. Global Burden of Disease Cancer Collaboration. Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996. PMID: 31560378; PMCID: PMC6777271. (Impact Factor: 31.78, Citations: 795)

46. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13. PMID: 32061315; PMCID: PMC7049905. (Impact Factor: 59.1, Citations: 932)

47. James SL et al. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017. Inj Prev. 2020 Oct;26(Supp 1):i96-i114. doi: 10.1136/injuryprev-2019-043494. Epub 2020 Apr 24. PMID: 32332142; PMCID: PMC7571366. (Impact Factor: 2.42, Citations: 105)

48. Haagsma JA et al. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017. Inj Prev. 2020 Oct;26(Supp 1):i12-i26. doi: 10.1136/injuryprev-2019-043296. Epub 2020 Jan 8. PMID: 31915273; PMCID: PMC7571356. (Impact Factor: 2.42, Citations: 14)

49. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. PMID: 30496103; PMCID: PMC6227606. (Impact Factor: 59.1, Citations: 3011)

50. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. PMID: 30496104; PMCID: PMC6227754. (Impact Factor: 59.1, Citations: 2942)

51. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8. PMID: 30496105; PMCID: PMC6227755. (Impact Factor: 59.1, Citations: 2197)

52. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. PMID: 30415748; PMCID: PMC6252083. (Impact Factor: 59.1, Citations: 1205)

53. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8. PMID: 28919119; PMCID: PMC5614451. (Impact Factor: 59.1, Citations: 859)

54. GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8. PMID: 30496102; PMCID: PMC6227504. (Impact Factor: 59.1, Citations: 568)

55. GBD Tuberculosis Collaborators. Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis. 2018 Dec;18(12):1329-1349. doi: 10.1016/S1473-3099(18)30625-X. PMID: 30507459; PMCID: PMC6250050. (Impact Factor: 25.071, Citations: 86) 

Talks

1. CME on COVID-19 (Jointly organized by Sanjay Gandhi Postgraduate Institute of Medical Sciences-GADVASU-Indian Virological Society-American Society of Microbiology on March 26, 2022)

2. Histocompatibility session: 26th International Congress of The Transplantation Society, Hong Kong 2016 (Association of KIR3DL1/3DS1 alleles with renal allograft rejection)

3. 12th International Summer School on Immunogenetics (Jointly organized by ASHI, APHIA) Ayutthaya, Thailand 2015 (Associations of Killer Immunoglobulin like receptors with childhood acute lymphoblastic leukemia among north Indian Population)